{
    "id": 3373,
    "fullName": "MTOR C1483Y",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MTOR C1483Y lies within TPR repeat 5 of the Mtor protein (UniProt.org). C1483Y confers a gain of function to the Mtor protein resulting in activation of mTORC1 signaling as indicated by increased phosphorylation of S6K1 (PMID: 24631838, PMID: 31483294, PMID: 26255626).",
            "references": [
                {
                    "id": 18016,
                    "pubMedId": 31483294,
                    "title": "Brain somatic mutations in MTOR reveal translational dysregulations underlying intractable focal epilepsy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31483294"
                },
                {
                    "id": 4468,
                    "pubMedId": 26255626,
                    "title": "Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26255626"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2475,
        "geneSymbol": "MTOR",
        "terms": [
            "MTOR",
            "FRAP",
            "FRAP1",
            "FRAP2",
            "RAFT1",
            "RAPT1",
            "SKS"
        ]
    },
    "variant": "C1483Y",
    "createDate": "02/26/2015",
    "updateDate": "03/04/2020",
    "referenceTranscriptCoordinates": {
        "id": 145125,
        "transcript": "NM_004958",
        "gDna": "chr1:g.11157173C>T",
        "cDna": "c.4448G>A",
        "protein": "p.C1483Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 7438,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sapanisertib (MLN0128) inhibited Mtor activation in transformed cells over expressing MTOR C1483Y in culture (PMID: 24631838).",
            "molecularProfile": {
                "id": 3183,
                "profileName": "MTOR C1483Y"
            },
            "therapy": {
                "id": 1282,
                "therapyName": "Sapanisertib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7439,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Apitolisib (GDC-0980) inhibited Mtor activation in transformed cells over expressing MTOR C1483Y in culture (PMID: 24631838).",
            "molecularProfile": {
                "id": 3183,
                "profileName": "MTOR C1483Y"
            },
            "therapy": {
                "id": 750,
                "therapyName": "GDC-0980",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7437,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Torin 1 inhibited Mtor activation in transformed cells over expressing MTOR C1483Y in culture (PMID: 24631838).",
            "molecularProfile": {
                "id": 3183,
                "profileName": "MTOR C1483Y"
            },
            "therapy": {
                "id": 2247,
                "therapyName": "Torin 1",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7484,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells over expressing MTOR C1483Y demonstrated decreased response to Rapamune (sirolimus) induced growth inhibition in culture (PMID: 26255626).",
            "molecularProfile": {
                "id": 3183,
                "profileName": "MTOR C1483Y"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "decreased response",
            "references": [
                {
                    "id": 4468,
                    "pubMedId": 26255626,
                    "title": "Point mutations of the mTOR-RHEB pathway in renal cell carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26255626"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 7485,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a human T cell leukemia cell line harboring both MTOR C1483Y and R2430M demonstrated hypersensitivity to Rapamune (sirolimus) induced growth inhibition in culture (PMID: 24631838).",
            "molecularProfile": {
                "id": 25517,
                "profileName": "MTOR C1483Y MTOR R2430M"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 5603,
                "name": "T-cell acute lymphoblastic leukemia",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1953,
                    "pubMedId": 24631838,
                    "title": "A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24631838"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 3183,
            "profileName": "MTOR C1483Y",
            "profileTreatmentApproaches": [
                {
                    "id": 687,
                    "name": "mTOR Inhibitor",
                    "profileName": "MTOR C1483Y"
                },
                {
                    "id": 2821,
                    "name": "mTORC2 Inhibitor",
                    "profileName": "MTOR C1483Y"
                },
                {
                    "id": 2822,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "MTOR C1483Y"
                }
            ]
        },
        {
            "id": 25517,
            "profileName": "MTOR C1483Y MTOR R2430M",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 145125,
            "transcript": "NM_004958",
            "gDna": "chr1:g.11157173C>T",
            "cDna": "c.4448G>A",
            "protein": "p.C1483Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145127,
            "transcript": "XM_011541166",
            "gDna": "chr1:g.11157173C>T",
            "cDna": "c.4448G>A",
            "protein": "p.C1483Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 145126,
            "transcript": "XM_005263438",
            "gDna": "chr1:g.11157173C>T",
            "cDna": "c.4448G>A",
            "protein": "p.C1483Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}